Tristel plc ("Tristel" or the "Company") Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of options by employees, it has issued and allotted 116,950 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 16 November 2017.

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 42,974,083 Ordinary Shares. Accordingly, the figure of 42,974,083 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash (Corporate Finance)

Giles Rolls (Corporate Finance)

Alice Lane (Corporate Broking)

Tristel plc published this content on 13 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 November 2017 13:43:02 UTC.

Original documenthttp://www.tristel.com/sites/default/files/tristel_plc_issue_of_equity_101117.pdf

Public permalinkhttp://www.publicnow.com/view/2861814E80EBDCDBA971CEC2B5E09BC0492AD52E